Table 1.
Demographics, baseline characteristics, and ovarian stimulation of donors
| HPC | 95 % CI | SSS | 95 % CI | |
|---|---|---|---|---|
| Number of donors and donation cycles | 218 | 214 | ||
| Age (years) | 24.7 ± 4.0 | (24.2–25.2) | 25.6 ± 3.9 | (25.1–26.1) |
| BMI (kg/m2) | 22.5 ± 2.9 | (22.1–22.9) | 22.9 ± 3.1 | (22.5–23.3) |
| Days of stimulation | 10.3 ± 1.4 | (10.1–10.5) | 10.4 ± 1.3 | (10.2–10.6) |
| rFSH dose (IU) | 1612.9 ± 528.7 | (1535.4–1690.4) | 1593.6 ± 513.6 | (1513.5–1673.7) |
| E2 on day of hCG (pg/ml) | 2606.9 ± 1369.1 | (2415.8–2798.0) | 2577.7 ± 1523.7 | (2367.1–2788.3) |
| P4 (ng/ml) | 0.96 ± 0.59 | (0.84–1.08) | 0.83 ± 0.48 | (0.75–0.91) |
| Total MII oocytes vitrified (mean per cycle) | 2532 (11.6 ± 3.3) | (11.2–12.0) | 2353 (11.0 ± 3.2) | (10.6–11.4) |
Unless otherwise indicated, values are mean ± SD with 95 % confidence limits in brackets
BMI body mass index, rFSH recombinant FSH